Mark Christopher Capone, President & C.E.O at MYRIAD GENETICS INC (MYGN), sold 90,000 shares at $38.00 ($3.4M) on 2018-05-30, disclosed to the SEC on 2018-06-01.
Open-market sale of $3.4M MYGN by President & C.E.O. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MYGN | SELL | 2018-07-13 | $3.3M | — | Filing → |
| MYGN | BUY | 2016-08-19 | $425K | — | Filing → |
| MYGN | SELL | 2014-02-25 | $3.6M | — | Filing → |